Love Hemp Group PLC - Warrant Exercise and Issue of Equity
RNS Number : 2612T
Love Hemp Group PLC
23 November 2021
 

23 November 2021

Love Hemp Group PLC

("Love Hemp" or the "Company")

 

Warrant Exercise, Issue of Equity and Issue of Warrants

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), the brand-led consumer goods company focussed on CBD health and wellness solutions, announces that it has issued a total of 46,317,979 ordinary shares of one pence each in the Company ("Ordinary Shares") as follows:

·    6,022,580 Ordinary Shares pursuant to the exercise of Warrants

·    40,295,399 Ordinary Shares pursuant to consulting, advisory and licensing agreements, including shares issued to 258 Marketing Limited as the first instalment of the contractual agreement with Anthony Joshua

The cash proceeds from the Warrant exercise amount to £61,129 and will be used for general working capital purposes.

Application will be made for the Ordinary Shares to be admitted to trading on the AQSE Growth Market and admission is expected to become effective, and dealings in the Ordinary Shares are expected to commence, on Friday, 26 November 2021.

Following these issues, the Company has 875,463,167 Ordinary Shares in issue, each share carrying the right to one vote. The figure of 875,463,167 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In addition, the Company has issued Warrants to subscribe for 1,082,571 Ordinary Shares, with an expiry date of 28 May 2023 and an exercise price of 3.5 pence per share.

-ENDS-

 

For further information please visit: www.lovehempgroup.com or contact: 

 

Love Hemp Group

Andrew Male
Chairman & Director

 

Anna Legge

Chief Communications Officer

+44 (0) 7926 397 675

andrew.male@lovehempgroup.com

 

 

+44 (0) 7500 773 415

anna.legge@lovehempgroup.com

 

Financial Advisor

Rupert Fane

H&P Advisory Limited

 

+44 (0) 20 7907 8500

rf@hannam.partners

 

AQSE Corporate Adviser

Mark Anwyl

Peterhouse Capital Limited

 

+44 (0) 20 7469 0930

ma@peterhousecap.com

 

Financial PR

Tim Blythe/Alice McLaren/Madeleine Gordon-Foxwell

Blytheweigh

 

+44 (0) 207 138 3204

lovehemp@blytheweigh.com

 

About Love Hemp Group

Love Hemp Group is a brand-led consumer goods company focussed on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics and topicals. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE:LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life,  to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXGIBDBCXDDGBX ]]>